Review article: historic changes of Helicobacter pylori -associated diseases
Review article: the management of autoimmune hepatitis beyond consensus guidelines
Meta-analysis: rapid infliximab infusions are safe
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System
Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data
Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis
Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan
Adherence to the Sydney System guidelines increases the detection of Helicobacter gastritis and intestinal metaplasia in 400 738 sets of gastric biopsies
The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study
Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease – organic disease or diseased organ?
Commentary: natural history and management of acute upper GI bleeding due to tumours
Letter: fatigue, a growing concern in inflammatory bowel diseases
Letter: oral fructose - breath hydrogen response, symptoms, both or neither?
Letter: extracorporeal photopheresis in refractory chronic active ulcerative colitis
Letter: inflammatory bowel disease guidelines and conflicts of interest
Letter: inflammatory bowel disease guidelines and conflicts of interest – authors' reply